OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Tumor Glycans for Cancer Therapy: Successes, Limitations, and Perspectives
Nora Berois, Álvaro Pittini, Eduardo Osinaga
Cancers (2022) Vol. 14, Iss. 3, pp. 645-645
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 102

Native N-glycome profiling of single cells and ng-level blood isolates using label-free capillary electrophoresis-mass spectrometry
Anne‐Lise Marie, Yunfan Gao, Alexander R. Ivanov
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9

Novel anticancer drug discovery efforts targeting glycosylation: the emergence of fluorinated monosaccharides analogs
Ana Costa, Andreia Teixeira, Celso A. Reis, et al.
Expert Opinion on Drug Discovery (2025), pp. 1-11
Closed Access | Times Cited: 1

The Use of Plant Viral Nanoparticles in Cancer Biotherapy—A Review
Mamorake Donty Komane, Prudence Ngalula Kayoka‐Kabongo, Daria A. Rutkowska
Viruses (2025) Vol. 17, Iss. 2, pp. 218-218
Open Access | Times Cited: 1

Trichinella spiralis as a Potential Antitumor Agent: An Update
Soheil Sadr, Zahra Yousefsani, Pouria Ahmadi Simab, et al.
World s Veterinary Journal (2023) Vol. 13, pp. 65-74
Open Access | Times Cited: 21

Aberrant Glycosylation as Immune Therapeutic Targets for Solid Tumors
Yasuyuki Matsumoto, Tongzhong Ju
Cancers (2023) Vol. 15, Iss. 14, pp. 3536-3536
Open Access | Times Cited: 21

Antitumor Mechanisms of Molecules Secreted by Trypanosoma cruzi in Colon and Breast Cancer: A Review
Soheil Sadr, Shakila Ghiassi, Narges Lotfalizadeh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2023) Vol. 23, Iss. 15, pp. 1710-1721
Closed Access | Times Cited: 20

Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer
Krishan Kumar, Shiv Govind Rawat, Manjit Manjit, et al.
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 126057-126057
Closed Access | Times Cited: 20

Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
Kankan Cao, Guodong Zhang, Moran Yang, et al.
Cancer Research (2023) Vol. 83, Iss. 13, pp. 2171-2186
Open Access | Times Cited: 18

Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy
Xueting Ren, Shuai Lin, Feng Guan, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 7, pp. 2607-2621
Open Access | Times Cited: 6

Unmasking the Deceptive Nature of Cancer Stem Cells: The Role of CD133 in Revealing Their Secrets
Julia Pospieszna, Hanna Dams-Kozłowska, Wachirawit Udomsak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10910-10910
Open Access | Times Cited: 14

Rewiring of the N-Glycome with prostate cancer progression and therapy resistance
William Butler, Colin T. McDowell, Qing Yang, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 13

Anti-glycan monoclonal antibodies: Basic research and clinical applications
Kara M. Gillmann, J. Sebastian Temme, Samantha Marglous, et al.
Current Opinion in Chemical Biology (2023) Vol. 74, pp. 102281-102281
Open Access | Times Cited: 13

Tumor-associated carbohydrate antigens of MUC1 – Implication in cancer development
Iwona Radziejewska
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116619-116619
Open Access | Times Cited: 5

Towards chemoenzymatic labeling strategies for profiling protein glycosylation
Yinping Tian, Shengzhou Ma, Liuqing Wen
Current Opinion in Chemical Biology (2024) Vol. 80, pp. 102460-102460
Closed Access | Times Cited: 5

Novel lectin-based chimeric antigen receptors target Gb3-positive tumour cells
Ana Valeria Meléndez, Rubí M.-H. Velasco Cárdenas, Simon Lagies, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 10
Open Access | Times Cited: 22

The role of viruses in cancer development versus cancer therapy: An oncological perspective
Hossein Javid, Alireza Sharbaf Mashhad, Shaghayegh Yazdani, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11127-11148
Open Access | Times Cited: 11

Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers
Maria Roxana Biricioiu, Mirela Sârbu, Raluca Ică, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1335-1335
Open Access | Times Cited: 4

Therapeutic Applications of Plant Virus Nanoparticles in Cancer Treatment and Nanomedicine
Muhammad Majid, Muhammad Safdar Hussain, Hamza Khaliq, et al.
Indus journal of bioscience research. (2025) Vol. 3, Iss. 1, pp. 429-437
Closed Access

Current Development of Therapeutic Vaccines in Lung Cancer
Joseph Kiran Banda, Sanjana Gangane, Fatima Ali Raza, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 185-185
Open Access

One-Step Labeling Strategy for the Profiling of Multiple Types of Protein Glycosylation
Yinping Tian, Yuqiu Wang, Ying Zhang, et al.
Analytical Chemistry (2025)
Closed Access

Investigation of new autoantibodies in urothelial bladder cancer for biomarker discovery using immunoproteomics
Samira Tabaei, Mohammadrasul Zareinejad, Mohammad Reza Haghshenas, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

GMMA decorated with mucin 1 Tn/STn mimetics elicit specific antibodies response and inhibit tumor growth
Elisa Pesce, Andrea Sodini, Elena Palmieri, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access

Protease-activated anti-Lewis Y antibody enhances selectivity and safety of glycan-targeting cancer therapy
Wen-Han Lee, Ying-Rou Shen, Bo‐Cheng Huang, et al.
International Journal of Biological Macromolecules (2025) Vol. 309, pp. 143176-143176
Closed Access

Novel Click Coupling Chemistry to Explore Glycan Recognition
Tianwei Jia, Akul Y. Mehta, Catherine A Tilton, et al.
ACS Central Science (2025)
Open Access

Page 1 - Next Page

Scroll to top